Pregnancy disorders linked to cardiovascular disease in menopausal women
A new study highlights gestational hypertension as a significant predictor of cardiovascular disease in menopausal women, challenging previous assumptions about preeclampsia’s role.
In an interview with Contemporary OB/GYN, Marie Tan, a fourth-year medical student at Drexel University College of Medicine, discussed a study analyzing the association between pregnancy-related disorders and cardiovascular disease in menopausal women.
The research focused on conditions such as preeclampsia, gestational hypertension, and gestational diabetes, which are known to increase the risk of cardiovascular disease in later life. Tan noted a lack of research on these pregnancy disorders in menopausal women, leading her to pursue this topic.
The study was a cross-sectional analysis that used data from a larger investigation known as the Breast Arterial Calcification Study. It involved 380 women aged a mean 81.6 years, primarily from Connecticut. With a 20% retention rate, many participants were lost because of death or lack of follow-up, but the remaining data provided valuable insights. The primary goal of the study was to evaluate whether pregnancy-related conditions are associated with an increased risk of cardiovascular disease in menopausal women.
Interestingly, the study found that gestational hypertension, rather than preeclampsia, was significantly associated with cardiovascular disease risk. This finding was unexpected since previous studies and meta-analyses have typically indicated preeclampsia as a stronger predictor of cardiovascular disease. Tan’s study did not show a similar association for either preeclampsia or gestational diabetes.
Tan emphasized the importance of understanding how pregnancy-related factors from decades earlier can continue to influence women's health as they age. With women comprising half of the global population and increasing in longevity, she stressed the need for medical professionals to consider pregnancy-related factors when assessing cardiovascular risk in older women. Given the current lack of research, Tan hopes her study will serve as a foundation for further exploration into how these early life conditions impact menopausal and postmenopausal women's health.
Increase in ED visits for hypertensive disorders from 2006 to 2020 reported
September 18th 2024In a recent study, reported rates on emergency department utilization for hypertensive disorders of pregnancy and the postpartum period were higher in 2020 than 2006, with rates especially high among non-Hispanic Black, Hispanic, and Asian patients.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
S3E20: Brooke Faught, NP on sexual health, trauma-informed care, and the perks of meeting in-person
December 3rd 2021In this episode of Pap Talk, we took you with us to the North American Menopause Society's recent Annual Meeting. Sexual health specialist Michael Krychman, MD, sat down with Brooke Faught, NP, to learn more about her work at the Women's Institute for Sexual Health, her role on the NAMS Planning Committee, and her tips for talking trauma with patients.
Listen
SKYLIGHT trials confirm safety and efficacy of fezolinetant against sleep disturbances
September 13th 2024At the 2024 Annual Meeting of The Menopause Society, the positive safety and efficacy data of fezolinetant against sleep disturbances from the SKYLIGHT 1 and 2 trials was presented.
Read More
